Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion type Assertion NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_head.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion description "[NAT2 mt/mt, CYP2E1*1A/*1A and GSTM1 null/null were observed to increase the risk of ATLI in tuberculosis patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_provenance.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion evidence source_evidence_literature NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_provenance.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion SIO_000772 18713495 NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_provenance.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion wasDerivedFrom befree-20150227 NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_provenance.
- NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_assertion wasGeneratedBy ECO_0000203 NP437956.RAcfOuGbquMTrG-5Gd5AeOml0lxd0_Bk4fb7pxHrhMm-s130_provenance.